These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 25315966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
    Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH.
    PLoS Pathog; 2013; 9(4):e1003264. PubMed ID: 23592988
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
    Ryan EJ, McNeela E, Murphy GA, Stewart H, O'hagan D, Pizza M, Rappuoli R, Mills KH.
    Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
    [Abstract] [Full Text] [Related]

  • 7. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
    Ausiello CM, Cassone A.
    mBio; 2014 Jun 10; 5(3):e01339-14. PubMed ID: 24917600
    [Abstract] [Full Text] [Related]

  • 8. Immunity to the respiratory pathogen Bordetella pertussis.
    Higgs R, Higgins SC, Ross PJ, Mills KH.
    Mucosal Immunol; 2012 Sep 10; 5(5):485-500. PubMed ID: 22718262
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH, Ross PJ, Allen AC, Wilk MM.
    Trends Microbiol; 2014 Feb 10; 22(2):49-52. PubMed ID: 24485284
    [Abstract] [Full Text] [Related]

  • 11. Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.
    Wolf MA, Boehm DT, DeJong MA, Wong TY, Sen-Kilic E, Hall JM, Blackwood CB, Weaver KL, Kelly CO, Kisamore CA, Bitzer GJ, Bevere JR, Barbier M, Damron FH.
    Infect Immun; 2021 Feb 16; 89(3):. PubMed ID: 33318136
    [Abstract] [Full Text] [Related]

  • 12. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice.
    Ryan M, Gothefors L, Storsaeter J, Mills KH.
    Dev Biol Stand; 1997 Feb 16; 89():297-305. PubMed ID: 9272363
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.
    Banus S, Stenger RM, Gremmer ER, Dormans JA, Mooi FR, Kimman TG, Vandebriel RJ.
    BMC Immunol; 2008 May 22; 9():21. PubMed ID: 18498620
    [Abstract] [Full Text] [Related]

  • 15. Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against Bordetella pertussis in a Mouse Model.
    Jiang W, Wang X, Su Y, Cai L, Li J, Liang J, Gu Q, Sun M, Shi L.
    Front Immunol; 2022 May 22; 13():878832. PubMed ID: 35493458
    [Abstract] [Full Text] [Related]

  • 16. Pertussis: Where did we go wrong and what can we do about it?
    Locht C.
    J Infect; 2016 Jul 05; 72 Suppl():S34-40. PubMed ID: 27161992
    [Abstract] [Full Text] [Related]

  • 17. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH, Gerdts V.
    J Infect Dis; 2014 Apr 01; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses.
    Raeven RHM, Rockx-Brouwer D, Kanojia G, van der Maas L, Bindels THE, Ten Have R, van Riet E, Metz B, Kersten GFA.
    Sci Rep; 2020 Apr 30; 10(1):7396. PubMed ID: 32355188
    [Abstract] [Full Text] [Related]

  • 20. Assessing the In Vivo Effectiveness of Cationic Lipid Nanoparticles with a Triple Adjuvant for Intranasal Vaccination against the Respiratory Pathogen Bordetella pertussis.
    Aibani N, Patel P, Buchanan R, Strom S, Wasan KM, Hancock REW, Gerdts V, Wasan EK.
    Mol Pharm; 2022 Jun 06; 19(6):1814-1824. PubMed ID: 35302764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.